We identified divergent UPR signaling between malignant CTCL and normal CD4+ T cells that involves the hyper-responsiveness of Hsp70 family members, HSPA5 and HSPA6. Here, HSPA5 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.